| Leanne Phillips, | |
|
50 Medical Park Dr E, Birmingham, AL 35235-3401 | |
| (205) 915-1011 | |
| Not Available |
| Full Name | Leanne Phillips |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 50 Medical Park Dr E, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013405273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13646 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Leanne Phillips, 6076 Clubhouse Dr, Trussville, AL 35173-3630 Ph: (205) 915-1011 | Leanne Phillips, 50 Medical Park Dr E, Birmingham, AL 35235-3401 Ph: (205) 915-1011 |
News Archive
Despite extensive research efforts, schizophrenia remains one of the least understood brain disorders. One promising area of research is in receptors on the surfaces of brain cells that help sense growth factors.
To meet the changing needs of people affected by this growing epidemic, the American Diabetes Association has launched a completely redesigned www.diabetes.org in English and Spanish. Even though diabetes is a growing epidemic, a recent survey conducted by the Association showed that Americans received a failing grade in diabetes awareness.
Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, together with the University of Ottawa, one of Canada's top ten research universities, today announced the signing of an exclusive global license agreement. The agreement provides commercial access for Bioniche to University of Ottawa's technology for botanical therapeutics (natural health) and pharmaceutical compounds for treating anxiety and related conditions in animal health, human health and aquaculture
In conjunction with clinical assessment and the ECG, simple and rapid blood tests have become the standard for the detection of myocardial infarction. Starting in the year 2000, recommendations by the European Society of Cardiology and other major cardiology societies worldwide have begun to state uniformly that a rise in cardiac troponins - sensitive and specific markers for dying cells in the heart - is a prerequisite for the clinical diagnosis of myocardial infarction.
Atherotech, Inc., developer of the VAP Cholesterol Test, has announced it has received a patent on its method to derive and report apolipoprotein B100 (apoB) using the Vertical Auto Profile (VAP) technology. The patent recognizes the unique ability of the VAP Cholesterol Test to accurately report apoB, the next milestone in heart disease risk assessment.
› Verified 8 days ago
Katerina Elaine Pappas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4616 Highway 280, Birmingham, AL 35242 Phone: 205-991-6248 | |
Lindsey Elmore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Lakeshore Dr, Birmingham, AL 35229 Phone: 205-726-4431 | |
Ms. Debra Mcconnell Larussa, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2000 Center Point Pkwy, Birmingham, AL 35215 Phone: 205-852-8001 Fax: 205-852-6879 | |
Dr. Joshua James Tessin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-5350 | |
James Andrew Carr, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 19th Street South, Birmingham, AL 35233 Phone: 205-933-8101 Fax: 205-558-4784 | |
Betty A Morris, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5511 Highway 280, Suite 301, Birmingham, AL 35242 Phone: 205-995-8388 Fax: 205-995-8897 |